Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-01 Sale |
2025-04-01 6:32 pm |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
503 | $64.05 | $32,217 | 33,108 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-03 8:46 pm |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
5,000 | $58.69 | $293,458 | 33,611 (Direct) |
View |
| 2025-02-25 Sale |
2025-02-27 6:32 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
21,697 | $58.1 | $1,260,681 | 173,756 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 6:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
5,000 | $56.3 | $281,517 | 38,611 (Direct) |
View |
| 2025-01-06 Sale |
2025-01-07 4:14 pm |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
10,000 | $50.01 | $500,060 | 43,611 (Direct) |
View |
| 2024-10-15 Sale |
2024-10-16 6:53 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $53.5 | $1,070,059 | 243,324 (Direct) |
View |
| 2024-10-08 Sale |
2024-10-09 5:39 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
20,000 | $53.29 | $1,065,743 | 686,744 (Direct) |
View |
| 2024-09-24 Sale |
2024-09-26 6:06 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $56.88 | $1,706,440 | 766,744 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-18 6:49 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $62.45 | $1,249,096 | 207,478 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-12 5:56 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $59.13 | $1,773,790 | 856,744 (Direct) |
View |
| 2024-08-20 Sale |
2024-08-21 6:03 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $61.4 | $1,228,020 | 241,898 (Direct) |
View |
| 2024-08-13 Sale |
2024-08-15 4:59 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $57.15 | $1,714,451 | 946,744 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:57 pm |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
29,881 | $56.53 | $1,689,294 | 69,874 (Direct) |
View |
| 2024-07-23 Sale |
2024-07-24 5:48 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $55 | $1,100,023 | 221,752 (Direct) |
View |
| 2024-07-22 Sale |
2024-07-23 4:37 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $53.93 | $269,662 | 15,480 (Direct) |
View |
| 2024-06-26 Sale |
2024-06-28 4:06 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $51.93 | $1,557,940 | 60,480 (Direct) |
View |
| 2024-06-18 Sale |
2024-06-20 4:17 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $49.43 | $494,260 | 179,891 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 4:15 pm |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
20,000 | $50.31 | $1,006,300 | 99,755 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-22 5:24 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $45.27 | $905,480 | 221,606 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-23 Tax Withholding |
2025-02-24 5:11 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,410 | $57.75 | 209,691 (Direct) |
View |
| 2025-02-23 Exercise |
2025-02-24 5:11 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
4,747 | $0 | 209,691 (Direct) |
View |
| 2025-02-23 Tax Withholding |
2025-02-24 5:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
3,775 | $57.75 | 49,522 (Direct) |
View |
| 2025-02-23 Exercise |
2025-02-24 5:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
7,012 | $0 | 49,522 (Direct) |
View |
| 2025-02-23 Tax Withholding |
2025-02-24 5:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
3,601 | $57.75 | 51,963 (Direct) |
View |
| 2025-02-23 Exercise |
2025-02-24 5:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
6,688 | $0 | 51,963 (Direct) |
View |
| 2025-02-23 Tax Withholding |
2025-02-24 5:01 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
12,081 | $57.75 | 801,027 (Direct) |
View |
| 2025-02-23 Exercise |
2025-02-24 5:01 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
22,436 | $0 | 801,027 (Direct) |
View |
| 2025-02-20 Option Award |
2025-02-21 6:52 pm |
2026-02-20 2035-02-20 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
23,132 | $0 | 23,132 (Direct) |
View |
| 2025-02-20 Option Award |
2025-02-21 6:50 pm |
2026-02-20 2035-02-20 |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
43,930 | $0 | 43,930 (Direct) |
View |
| 2025-02-20 Option Award |
2025-02-21 6:49 pm |
2026-02-20 2035-02-20 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
43,930 | $0 | 43,930 (Direct) |
View |
| 2025-02-20 Option Award |
2025-02-21 6:47 pm |
2026-02-20 2035-02-20 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
138,065 | $0 | 138,065 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-18 6:42 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
34,652 | $0 | 207,754 (Direct) |
View |
| 2025-02-15 Tax Withholding |
2025-02-18 6:42 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
15,292 | $58.29 | 207,754 (Direct) |
View |
| 2025-02-16 Exercise |
2025-02-18 6:41 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
22,205 | $0 | 34,844 (Direct) |
View |
| 2025-02-16 Tax Withholding |
2025-02-18 6:41 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
11,955 | $58.29 | 34,844 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-18 6:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
29,085 | $0 | 44,564 (Direct) |
View |
| 2025-02-15 Tax Withholding |
2025-02-18 6:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
15,752 | $58.29 | 44,564 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-18 6:37 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
122,786 | $0 | 778,122 (Direct) |
View |
| 2025-02-15 Tax Withholding |
2025-02-18 6:37 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
66,166 | $58.29 | 778,122 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 6:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
36,702 | $0 | 52,701 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 6:11 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
48,067 | $0 | 62,093 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 6:09 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
46,868 | $0 | 61,190 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 6:08 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
164,380 | $0 | 222,589 (Direct) |
View |
| 2025-01-03 Tax Withholding |
2025-01-06 5:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
4,289 | $47.74 | 22,613 (Direct) |
View |
| 2025-01-03 Exercise |
2025-01-06 5:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
7,611 | $0 | 22,613 (Direct) |
View |
| 2024-11-29 Gift |
2024-12-03 4:05 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
10,470 | $0 | 183,035 (Direct) |
View |
| 2024-11-29 Gift |
2024-12-03 4:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
10,000 | $0 | 666,744 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-16 6:53 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
5,509 | $16.65 | 243,324 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-16 6:53 pm |
N/A 2029-02-12 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 243,324 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-16 6:53 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
14,491 | $19.98 | 243,324 (Direct) |
View |
| 2024-10-08 Exercise |
2024-10-09 5:39 pm |
N/A 2025-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
20,000 | $13.87 | 686,744 (Direct) |
View |
| 2024-09-24 Exercise |
2024-09-26 6:06 pm |
N/A 2025-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $13.87 | 766,744 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-18 6:49 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $16.65 | 207,478 (Direct) |
View |
| 2024-09-17 Exercise |
2024-09-18 6:49 pm |
N/A 2029-02-12 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 207,478 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-12 5:56 pm |
N/A 2025-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $13.87 | 856,744 (Direct) |
View |
| 2024-08-27 Exercise |
2024-08-27 7:49 pm |
N/A 2028-02-14 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
5,580 | $0 | 173,756 (Direct) |
View |
| 2024-08-27 Exercise |
2024-08-27 7:49 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
5,580 | $18.41 | 173,756 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-21 6:03 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $16.65 | 241,898 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-21 6:03 pm |
N/A 2029-02-12 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 241,898 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 4:59 pm |
N/A 2025-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $13.87 | 946,744 (Direct) |
View |
| 2024-07-24 Exercise |
2024-07-24 5:48 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,285 | $16.65 | 221,752 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-24 5:48 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
11,715 | $8.11 | 221,752 (Direct) |
View |
| 2024-07-23 Exercise |
2024-07-24 5:48 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 221,752 (Direct) |
View |
| 2024-07-22 Exercise |
2024-07-23 4:37 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $22.5 | 15,480 (Direct) |
View |
| 2024-07-22 Exercise |
2024-07-23 4:37 pm |
N/A 2025-07-01 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $0 | 15,480 (Direct) |
View |
| 2024-06-26 Exercise |
2024-06-28 4:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $22.5 | 60,480 (Direct) |
View |
| 2024-06-26 Exercise |
2024-06-28 4:06 pm |
N/A 2025-07-01 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $0 | 60,480 (Direct) |
View |
| 2024-06-18 Exercise |
2024-06-20 4:17 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $8.11 | 179,891 (Direct) |
View |
| 2024-06-18 Exercise |
2024-06-20 4:17 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 179,891 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:17 pm |
2025-06-12 N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER |
20,137 | $0 | 20,137 (Direct) |
View |
| 2024-05-21 Exercise |
2024-05-22 5:24 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $8.11 | 221,606 (Direct) |
View |
| 2024-05-21 Exercise |
2024-05-22 5:24 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 221,606 (Direct) |
View |